Nahidah Ibrahim Hammadi1, Yusuf Abba2, Mohd Noor Mohd Hezmee3, Intan Shameha Abdul Razak3, Alhaji Zubair Jaji3, Tijani Isa4, Saffanah Khuder Mahmood3, Md Zuki Abu Bakar Zakaria5. 1. Department of Veterinary Pre-Clinical Science, Faculty of Veterinary Medicine,, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia. homamm728@gmail.com. 2. Department of Veterinary Pathology and Microbiology Faculty of Veterinary Medicine,, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia. 3. Department of Veterinary Pre-Clinical Science, Faculty of Veterinary Medicine,, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia. 4. Department of Microbiology, Faculty of Science, University of Maiduguri, Borno State, Maiduguri, Nigeria. 5. Department of Veterinary Pre-Clinical Science, Faculty of Veterinary Medicine,, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia. zuki@upm.edu.my.
Abstract
PURPOSE: Here, we explored the formulation of a calcium carbonate nanoparticle delivery system aimed at enhancing docetaxel (DTX) release in breast cancer. METHODS: The designed nano- anticancer formulation was characterized thorough X-ray diffraction (XRD), Fourier transformed infrared (FTIR), transmission electron microscopy (TEM) and field emission scanning electron microscopy (FESEM) and Brunauer-Emmett-Teller (BET) methods. The nano- anticancer formulation (DTX- CaCO3NP) was evaluated for drug delivery properties thorough in vitro release study in human body simulated solution at pH 7.4 and intracellular lysosomal pH 4.8. RESULTS: Characterization revealed the successful synthesis of DTX- CaCO3NP, which had a sustained release at pH 7.4. TEM showed uniformly distributed pleomorphic shaped pure aragonite particles. The highest entrapment efficiency (96%) and loading content (11.5%) were obtained at docetaxel to nanoparticles ratio of 1:4. The XRD patterns revealed strong crystallizations in all the nanoparticles formulation, while FTIR showed chemical interactions between the drug and nanoparticles with negligible positional shift in the peaks before and after DTX loading. BET analysis showed similar isotherms before and after DTX loading. The designed DTX- CaCO3NP had lower (p < 0.05) cytotoxity against MCF-7 cells than DTX at 24 h but comparable (p > 0.05) effects at 48 h and 72 h. However, the DTX- CaCO3NP released less than 80% of bond DTX at 48 and 72 h but showed comparable effects with free DTX. CONCLUSIONS: The results showed that the developed DTX- CaCO3NP released DTX slower at pH 7.4 and had comparable cytotoxicity with free DTX at 48 and 72 h in MCF-7 cells.
PURPOSE: Here, we explored the formulation of a calcium carbonate nanoparticle delivery system aimed at enhancing docetaxel (DTX) release in breast cancer. METHODS: The designed nano- anticancer formulation was characterized thorough X-ray diffraction (XRD), Fourier transformed infrared (FTIR), transmission electron microscopy (TEM) and field emission scanning electron microscopy (FESEM) and Brunauer-Emmett-Teller (BET) methods. The nano- anticancer formulation (DTX- CaCO3NP) was evaluated for drug delivery properties thorough in vitro release study in human body simulated solution at pH 7.4 and intracellular lysosomal pH 4.8. RESULTS: Characterization revealed the successful synthesis of DTX- CaCO3NP, which had a sustained release at pH 7.4. TEM showed uniformly distributed pleomorphic shaped pure aragonite particles. The highest entrapment efficiency (96%) and loading content (11.5%) were obtained at docetaxel to nanoparticles ratio of 1:4. The XRD patterns revealed strong crystallizations in all the nanoparticles formulation, while FTIR showed chemical interactions between the drug and nanoparticles with negligible positional shift in the peaks before and after DTX loading. BET analysis showed similar isotherms before and after DTX loading. The designed DTX- CaCO3NP had lower (p < 0.05) cytotoxity against MCF-7 cells than DTX at 24 h but comparable (p > 0.05) effects at 48 h and 72 h. However, the DTX- CaCO3NP released less than 80% of bond DTX at 48 and 72 h but showed comparable effects with free DTX. CONCLUSIONS: The results showed that the developed DTX- CaCO3NP released DTX slower at pH 7.4 and had comparable cytotoxicity with free DTX at 48 and 72 h in MCF-7 cells.
Entities:
Keywords:
breast cancer; cancer therapy; cockle shell- derived calcium carbonate nanoparticles; drug delivery; nano- anticancer
Authors: Ibrahima Youm; Joseph D Bazzil; Joseph W Otto; Anthony N Caruso; James B Murowchick; Bi-Botti C Youan Journal: AAPS J Date: 2014-04-04 Impact factor: 4.009
Authors: Tijani Isa; Zuki Abu Bakar Zakaria; Yaya Rukayadi; Mohd Noor Mohd Hezmee; Alhaji Zubair Jaji; Mustapha Umar Imam; Nahidah Ibrahim Hammadi; Saffanah Khuder Mahmood Journal: Int J Mol Sci Date: 2016-05-19 Impact factor: 5.923
Authors: Keun Sang Oh; Kyungim Kim; Byeong Deok Yoon; Hye Jin Lee; Dal Yong Park; Eun-Yeong Kim; Kiho Lee; Jae Hong Seo; Soon Hong Yuk Journal: Int J Nanomedicine Date: 2016-03-16
Authors: Nahidah Ibrahim Hammadi; Yusuf Abba; Mohd Noor Mohd Hezmee; Intan Shameha Abdul Razak; Aminu Umar Kura; Zuki Abu Bakar Zakaria Journal: In Vitro Cell Dev Biol Anim Date: 2017-09-15 Impact factor: 2.416
Authors: Ahmed Al Saqr; Shahid Ud Din Wani; H V Gangadharappa; Mohammed F Aldawsari; El-Sayed Khafagy; Amr S Abu Lila Journal: Polymers (Basel) Date: 2021-04-27 Impact factor: 4.329
Authors: Sherifat Banke Idris; Arifah Abdul Kadir; Jesse F F Abdullah; Siti-Zubaidah Ramanoon; Muhammad Abdul Basit; Md Zuki Z A Abubakar Journal: Front Vet Sci Date: 2020-06-16
Authors: Ahmed Hamidu; Ajat Mokrish; Rozaihan Mansor; Intan Shameha Abdul Razak; Abubakar Danmaigoro; Alhaji Zubair Jaji; Zuki Abu Bakar Journal: Int J Nanomedicine Date: 2019-05-20
Authors: Maryam Muhammad Mailafiya; Kabeer Abubakar; Samaila Musa Chiroma; Abubakar Danmaigoro; Ezamin Bin Abdul Rahim; Mohamad Aris Mohd Moklas; Zuki Abu Bakar Zakaria Journal: Saudi J Biol Sci Date: 2020-03-12 Impact factor: 4.219
Authors: Abubakar Danmaigoro; Gayathri Thevi Selvarajah; Mohd Hezmee Mohd Noor; Rozi Mahmud; Md Zuki Abu Bakar Journal: Adv Pharmacol Sci Date: 2018-06-24